1Sudoh T,Kangawa K,Minamino N, et al.A new natriuretic peptide in porcine brain. Nature, 1988,332:78-81.
2Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene. Production in the ventricle.Hypertention, 1991,17:1152-1155.
3Ogawa Y, Itoh H,Nakao K. Molecular biology and biochemistry of natriuretic peptide family. Clin Exp Pharmacol Physiol, 1995,22 : 49-53.
4Omland T,Aakvaag A,Bonarjee W, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptideand Nterminal proatrial natriuretic peptide. Circulation,1996,93 : 1963-1969.
5Inoue S, Murakami Y, Sano K, et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation.J Card Fail,2000,6:92-96.
6Stevenson WG, Stevenson LW. Prevention of sudden death in heart failure. J cardiovasc Electrophysiol, 2001, 12 : 112-114.
7Prystowsky EN, Nisam S. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond.Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial. Am J Cardiol,2000,86:1214-1215.
8Berger R, Huelsman M, Strecker K, et al. B-type natruretic peptide predicts sudden death in patients with chronic heart failure. Circulation, 2002,105 : 2392-2397.
9Benjamin EJ,Levy D, Vaziri SM,et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study. JAMA, 1994,271:840-844.
10Mabuchi N,Tsutamoto T, Maeda K,et al. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J, 2000,64: 765-771.
4Amalia H,Kostas T,Marina T,et al.BNP plasma levels or left atrial dimension for the prediction of paroxysmal atrial fibrillation in subjects with essential hypertension[J].Am Heart J,2004,17(4pt2):228-232.
